Enhabit (EHAB) closed out FY 2025 with fourth quarter revenue of US$270.4 million and basic EPS of a US$0.76 loss, while trailing 12 month revenue came in at US$1.06 billion and basic EPS at a US$0.09 loss. Over the past year, the company has reported quarterly revenue ranging from US$259.9 million to US$270.4 million, with basic EPS moving from a US$0.35 loss in Q1 2025 to a US$0.10 loss in Q2 and a US$0.22 loss in Q3 before the Q4 loss. This presents a mixed picture on profitability. For investors, the key consideration is whether the current top line scale can translate more consistently into improved margins and a clearer path to sustainable earnings.

See our full analysis for Enhabit.

With the headline numbers reported, the next step is to compare these results with prevailing market narratives to identify which views about Enhabit remain supported and which may be challenged by the latest margin trends.

TTM loss of US$4.6 million keeps profitability in focus

• Over the last 12 months, Enhabit generated about US$1.06 billion in revenue but reported a net loss of US$4.6 million and basic EPS of a US$0.09 loss, so the core question for you is how quickly that small loss can be turned into a consistent profit.
• Supporters of the bullish view point to analysts expecting earnings to reach US$34.4 million and EPS of US$0.63 by around 2028, and argue that a move from a US$4.6 million loss today to positive earnings would validate a margin improvement story. Critics will note that losses have grown at about 47.3% per year over five years, which keeps execution risk very visible.

Valuation gap vs DCF and 13.8 analyst target

• The stock trades at US$13.77 per share with a P/S of 0.7x, compared with peer and industry averages of 1.0x and 1.2x, and sits well below both the US$13.80 analyst consensus price target and the US$35.23 DCF fair value that has been provided.
• Fans of the bullish narrative argue that trading around 60% below the cited DCF fair value and below sector P/S multiples heavily supports a value angle. However, the current trailing loss, modest 4.8% revenue growth and five year loss expansion mean the market may be treating those forecasts cautiously until profitability actually shows up in the numbers.
• Consensus narrative notes that moving margins from roughly a 0.4% loss to a 2.4% profit over three years is central to closing that valuation gap. This would require earnings to rise from a US$4.6 million loss to about US$28.7 million.
• What stands out is that the gap between the current price and the US$13.80 target is small, while the gap to the US$35.23 DCF fair value is large. You are effectively choosing which reference point you trust more.

Curious how bulls frame that upside against the current loss profile and modest top line growth, and what assumptions they lean on for 2028 profitability, check out the 🐂 Enhabit Bull Case.

Quarterly swings test the bearish case on margins

• Within FY 2025, net income moved from a profit of US$17.8 million in Q1 to US$5.2 million in Q2, US$11.1 million in Q3 and then a loss of US$38.7 million in Q4, so results have shifted between profit and loss even though quarterly revenue stayed in a tight band of roughly US$260 million to US$270 million.
• Skeptics in the bearish narrative highlight that this pattern, together with five years of widening losses, supports concern about earnings quality and sensitivity to reimbursement changes. At the same time, the fact that some quarters within the same year were profitable shows that margin outcomes are not locked in one direction and can respond to operational or pricing changes.
• Bears argue that reliance on periodic payer renegotiations and rate pressure from Medicare and Medicare Advantage could cap margins, and they point to the US$38.7 million Q4 loss as an example of how fast profitability can swing.
• At the same time, seven consecutive quarters of hospice census growth and hospice adjusted EBITDA margin of 27.3% that are referenced in the narratives suggest one segment can support earnings, which partly challenges the idea that the whole business is structurally unable to earn healthy margins.

If you want to see how skeptics connect those swings in profit and loss to reimbursement risk and leverage, and what needs to go right to avoid that downside, read the 🐻 Enhabit Bear Case.

Next Steps

To see how these results tie into long-term growth, risks, and valuation, check out the full range of community narratives for Enhabit on Simply Wall St. Add the company to your watchlist or portfolio so you'll be alerted when the story evolves.

Given the mixed signals around Enhabit's losses, targets and future earnings, it makes sense to move quickly and test the data against your own expectations by reviewing the 3 key rewards and 1 important warning sign.

See What Else Is Out There

Enhabit’s recent results show revenue holding steady while profits swing between gains and losses, leaving margin stability and consistent earnings still unproven.

If those swings make you cautious about earnings risk, it is worth checking companies screened for steadier profiles using the 72 resilient stocks with low risk scores.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.